- Home
- / Genflow Biosciences
Genflow Biosciences
Stock Price
£0
2024-10-29
Market Capitalization
£6.3 M
2024-10-29
Genflow Biosciences Summary
Company Summary
- Overview
- Genflow Biosciences is a company that develops biological interventions. It engages in the commercialization of novel therapeutics targeting aging in dogs and humans.
- Type
- Public
- Status
- Active
- Founded
- 2001
- HQ
- London, GB | view all locations
- Website
- https://genflowbio.com/
- Cybersecurity rating
- Sectors
Table of Contents
Key People
Tamara Joseph, Chairperson
Guy Charles Fanneau De La Horie, Non-Executive Director
Peter King-Lewis, Non-Executive Director
LocationsView all
1 location detected
London, England HQ
United Kingdom
Unit 1, 15 Ingestre Pl
Genflow Biosciences Financials
Summary Financials
- Gross profit (FY, 2025)
- £595.0K
- Net income (FY, 2025)
- (£1.4M)
- Cash (FY, 2025)
- £112.0K
- EBIT (FY, 2025)
- (£1.1M)